Anne Galy
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 28
- Hematopoietic Stem Cell Transplantation 20
- Genetics 61
- Virus-based gene therapy research 56
- Co-authors
- Hergen SpitsMarilyn TravisAmy WesaBenjamin P.C. ChenSabine CharrierRoseline YaoDiego J. LaderachAndràs Páldi
- Journals
- Blood (22 papers)Molecular Therapy (11 papers)Human Gene Therapy (8 papers)Gene Therapy (8 papers)Molecular Therapy — Methods & Clinical Development (7 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Anne Galy
152 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 2.7k
- Hematology 939
- Genetics 1.6k
- Genetics 558
- Oncology 1.3k
Countries citing papers authored by Anne Galy
This map shows the geographic impact of Anne Galy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Galy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Galy more than expected).
Fields of papers citing papers by Anne Galy
This network shows the impact of papers produced by Anne Galy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Galy. The network helps show where Anne Galy may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Galy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | Impact of sequential bilateral intravitreal injection of rAAV2/2-ND4 on ocular and systemic humoral immune status in non-human primates | 2018 | 1 |
| 6 | 2017 | 11 | |
| 7 | 2017 | 42 | |
| 8 | 2017 | 31 | |
| 9 | 2017 | 1 | |
| 10 | 2017 | 2 | |
| 11 | Preliminary safety and tolerability results of intravitreal administration of GS010, a recombinant adeno-associated viral vector serotype 2 (rAAV2/2) containing human wildtype mitochondrial NADH dehydrogenase 4 (ND4) gene in patients with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial DNA mutation | 2015 | 1 |
| 12 | Safety, local tolerability and biodistribution of GS010 (AAV2/2-ND4), a gene therapy medicinal product in development for Leber Hereditary Optic Neuropathy (LHON) | 2014 | 1 |
| 13 | 2013 | 45 | |
| 14 | 2010 | 31 | |
| 15 | 2009 | 18 | |
| 16 | 2009 | 13 | |
| 17 | 2003 | 62 | |
| 18 | 2003 | 26 | |
| 19 | 2001 | 48 | |
| 20 | 1993 | 134 |
About Anne Galy
Anne Galy is a scholar working on Hematology, Genetics, Immunology, Genetics and Oncology, having authored 155 papers that have together received 6.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (56 papers), CAR-T cell therapy research (31 papers), RNA Interference and Gene Delivery (30 papers), T-cell and B-cell Immunology (30 papers), Immunotherapy and Immune Responses (29 papers), Immune Cell Function and Interaction (25 papers), CRISPR and Genetic Engineering (20 papers) and Hematopoietic Stem Cell Transplantation (20 papers). The work is most often cited by research in Immunology (2.7k citations), Hematology (939 citations), Genetics (1.6k citations), Genetics (558 citations) and Oncology (1.3k citations). Anne Galy has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Hergen Spits, Marilyn Travis, Amy Wesa, Benjamin P.C. Chen, Sabine Charrier, Roseline Yao, Diego J. Laderach, Andràs Páldi, Barbara Gayraud-Morel and Laetitia van Wittenberghe. Their work appears in journals such as Blood, Molecular Therapy, Human Gene Therapy, Gene Therapy and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.